# Aromatase Inhibitor Host Factors Study

> **NCT01669343** · NA · COMPLETED · sponsor: **Samuel Lunenfeld Research Institute, Mount Sinai Hospital** · enrollment: 121 (actual)

## Conditions studied

- Breast Neoplasms

## Interventions

- **DRUG:** Letrozole

## Key facts

- **NCT ID:** NCT01669343
- **Lead sponsor:** Samuel Lunenfeld Research Institute, Mount Sinai Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-10
- **Primary completion:** 2016-12
- **Final completion:** 2016-12
- **Target enrollment:** 121 (ACTUAL)
- **Last updated:** 2021-05-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01669343

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01669343, "Aromatase Inhibitor Host Factors Study". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01669343. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*